SMSbiotech
  • Contact us760-290-3400
  • Home
  • About Us
  • Science
    • Science
    • Insight
      • ∙ Aging
      • ∙ Blood Vessel Formation and Cancer
      • ∙ Blood Vessel Regression
      • ∙ Cancer
      • ∙ Cell Based Microfluidics
      • ∙ Cellular Spheroids, Aggregates, Assembly
      • ∙ Diabetic Ulcers
      • ∙ ECM and Aging
      • ∙ ECM and Cancer
      • ∙ ECM and Tissue Repair
      • ∙ Exosomes
      • ∙ Organoids
      • ∙ Stem Cells
    • Upcoming Presentations
    • Past Presentations
  • Products
    • Products
    • Resources
      • Application Notes
      • Instructions
      • MSDS Sheets
      • White Papers
  • Pipeline
  • News
  • COVID-19 Treatment Proposal
  • Contact Us
Press enter to begin your search
Category

Upcoming Presentations

  • Categories

    • Company News 21
      • Interview 7
      • Past Presentations 12
    • Coronavirus 17
    • Products 2
      • ANGIOstream – VG 4
      • INM – Inductive Niche Module 1
    • Science 2
      • Insight 26
        • ∙ Aging 4
        • ∙ Blood Vessel Formation and Cancer 2
        • ∙ Blood Vessel Regression 1
        • ∙ Cancer 3
        • ∙ Cell Based Microfluidics 1
        • ∙ Cellular Spheroids, Aggregates, Assembly 3
        • ∙ Diabetic Ulcers 2
        • ∙ ECM and Aging 4
        • ∙ ECM and Cancer 2
        • ∙ ECM and Tissue Repair 1
        • ∙ Exosomes 3
        • ∙ Organoids 1
        • ∙ Stem Cells 6

Recent Posts

  • SMSbiotech Engages Exemplar Capital for Strategic Investment Banking Services
  • MSC’s In the Treatment of COVID-19
  • Cell therapy for cardiac regeneration? New Research is promising.
  • Interviews with Dr. Roger Schechter: Episode 5: COVID-19 Part 2 (Effects and Solutions)
  • Interviews with Dr. Roger Schechter EPISODE 4: COVID-19 Part 1

Archives

  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • October 2019
  • August 2019
  • June 2019
  • September 2018
  • August 2018
  • March 2018
  • February 2018
  • October 2016
  • June 2016
  • March 2015
  • October 2013

SMSbiotech

SMSbiotech, Inc. is a California-based biotech company. Our goal is to revolutionize how the life sciences industry explores, examines, assesses and manipulates cells, drugs and toxins. Our stem cell technology will lead to the development of more efficient and relevant medicines.

Information

  • Careers
  • Investors
  • Pipeline

quick links

Home Contact UsTerms of Sale Terms & Conditions

Contact Details

1825 DIAMOND ST STE 101
SAN MARCOS, CA 92078

UNITED STATES

CALL US: 760-290-3406

EMAIL US: INFO@SMSBIOTECH.COM TECHNICALSUPPORT@SMSBIOTECH.COM

© 2019 - SMSbiotech. All Right Reserved.

    • Home
    • About Us
    • Science
      • Science
      • Insight
        • ∙ Aging
        • ∙ Blood Vessel Formation and Cancer
        • ∙ Blood Vessel Regression
        • ∙ Cancer
        • ∙ Cell Based Microfluidics
        • ∙ Cellular Spheroids, Aggregates, Assembly
        • ∙ Diabetic Ulcers
        • ∙ ECM and Aging
        • ∙ ECM and Cancer
        • ∙ ECM and Tissue Repair
        • ∙ Exosomes
        • ∙ Organoids
        • ∙ Stem Cells
      • Upcoming Presentations
      • Past Presentations
    • Products
      • Products
      • Resources
        • Application Notes
        • Instructions
        • MSDS Sheets
        • White Papers
    • Pipeline
    • News
    • COVID-19 Treatment Proposal
    • Contact Us
      error: Content is Property of SMSbiotech